Curculigoside inhibits osteoarthritis via the regulation of NLRP3 pathway
European Journal of Histochemistry · 2023
DOI: 10.4081/ejh.2023.3896 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Histochemistry, 2023. Verfasst von Xufei Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medi…. Hauptthemen laut MEDLINE: Osteoarthritis, Cartilage, Articular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Osteoarthritis (OA) is characterized by degenerative articular cartilage. Nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) plays an important role in inflammation. This study aims to investigate whether protective effects of curculigoside on OA are medicated by the regulation of NLRP3 pathway. Destabilization of the medial meniscus (DMM) was performed to build an OA mouse model. After surgery, OA mice were treated with curculigoside. Immunohistochemistry was conducted to evaluate OA cartilage. In addition, human chondrocytes were isolated and treated with curculigoside. The mRNA and protein expression of iNOS, MMP-9, NLRP3 was detected by PCR and Western blot analysis. Curculigoside inhibited mRNA and protein levels of iNOS and MMP-9 induced by DMM surgery in a dose-dependent manner. Furthermore, the expression of NLRP3, NF-κB and PKR was downregulated after curculigoside administration. Moreover, curculigoside reversed the effects of IL-1β on MMP-9, iNOS and type II collagen expression at mRNA and protein levels in human chondrocytes in a dose-dependent manner. In conclusion, curculigoside exhibits beneficial effect on cartilage via the inhibition of NLRP3 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan; Tongji Hospital, Tongji Medical College, Huaz…
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan; Department of Rehabilitation, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hos…
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan; Department of General Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Ho…
Zitieren
APA
Wang, X., Liu, Y., Zhou, Y., Zhou, Y., & Li, Y. (2023). Curculigoside inhibits osteoarthritis via the regulation of NLRP3 pathway. European Journal of Histochemistry. https://doi.org/10.4081/ejh.2023.3896
Vancouver
Wang X, Liu Y, Zhou Y, Zhou Y, Li Y. Curculigoside inhibits osteoarthritis via the regulation of NLRP3 pathway. European Journal of Histochemistry. 2023. doi:10.4081/ejh.2023.3896
BibTeX
@article{Wang2023,
author = {Wang, Xufei and Liu, Yinlian and Zhou, Yongnian and Zhou, Yang and Li, Yueping},
title = {Curculigoside inhibits osteoarthritis via the regulation of NLRP3 pathway},
journal = {European Journal of Histochemistry},
year = {2023},
doi = {10.4081/ejh.2023.3896}
}
EUVIMED